browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
658fe6c1-d854-4753-9ce3-067e1e27cb03
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:46:27
Income (reported)
Expenses (reported)
$1,200,000
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

DAVITA INC.

Contact
JOELLE THORNHILL
Phone
+1 202-478-8189
Address
zip:20004, city:Washington, state:DC, street:601 Pennsylvania Avenue, NW Suite 225
Client

DAVITA INC

State
DC
Country
US
Government-entity client
false
Effective date
2007-08-14
Issues lobbied + lobbyists (3)

HCR — Health Issues

H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entities (KCE) benchmarks Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options

Lobbyists:

Government entities lobbied: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entities (KCE) benchmarks Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options

Lobbyists:

Government entities lobbied: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

VET — Veterans

Issues related to Veterans Affairs and dialysis H.R. 3944, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, provisions related to dialysis

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.